The administration of Freund's adjuvant to rats induces a disease characterized by inflammatory lesions of synovial membrane, eye, skin, and genitourinary system (Pearson and Wood, 1959) . Adjuvantinduced disease (AID) has been compared to rheumatoid arthritis and Reiter's syndrome in man (Pearson, Waksman, and Sharp, 1961) . AID is generally considered to be a disease of thymicdependent cell-mediated immunity, mainly because it can be transferred between highly inbred animals by means of intact lymphoid cells (Waksman and Wennersten, 1963) .
The possible virus aetiology of AID has been discussed in previous studies (Kapusta and Mendelson, 1969) . The mixed lymphocyte proliferative response in vitro was studied using spleen cells from normal and Freund's adjuvant-treated rats from the same inbred strain in order to determine whether there were significant virus-induced surface antigenic differences between these two populations of cells. The proliferative responses of lymphoid cells from adjuvant-treated rats was found to be unpredictable. In order to clarify this problem, it was decided to study the responsiveness of these cells to various mitogens.
The results to be presented demonstrate that Freund's adjuvant alters the responses oflymphocytes from various lymphoid organs to phytohaemagglutinin (PHA) and pokeweed mitogen (PWM) in widely different ways. Further, these results differ from those previously reported in mice (Scott, 1972 a,b) .
The differences noted may, in part, explain why the rat is the only species which develops a rheumatic disease in response to adjuvant administration.
Material and Methods

RATS
Highly inbred male Fisher rats (Simonsen Lab., Gilroy, California) weighing between 180 and 220 g., housed in groups of four or five in large cages with wire mesh floors, and receiving a diet of commercial food pellets and water ad lib., were used throughout this study.
ADJUVANT INJECTION
Desiccated Mycobacterium butyricum (Difco Lab., Detroit, Michigan) was suspended in light mineral oil (Fisher) to give a suspension of 6 mg. M. butyricum per ml. Normal saline was added in a ratio of 1/50 v/v and the suspension was emulsified for 10 min. in a Sorvall OmniMixer at maximum speed and then autoclaved. A 21-gauge needle was used to inject 0-1 ml. of this adjuvant into the skin of the distal third of the tail.
CELL SUSPENSION AND CULTURES
Spleen, inguinal lymph node, and thymus cell suspensions were prepared by gently pressing those organs through a 50-mesh screen into cold medium 199 (Microbiological Associates, Bethesda, Maryland). Bone marrow cell suspensions were obtained by cutting the distal and proximal ends of each femur and tibia and flushing the marrow cavity with medium 199. The cells were then centrifuged at 100 g. for 10 min., the supernatant discarded, and the cells re-suspended in medium forcounting. The mitogenic response to bacterial lipopolysaccharide (LPS) was studied in the same way. No differences were noted from normal. LPS was generally poorly mitogenic for rat spleen, blood, thymus, and lymph node lymphocytes. Bone marrow cells failed to respond to LPS.
The AID rats showed atrophy of the thymus gland (Table II) . Atrophy was present by Day 7 and persisted throughout the experiment.
Similar studies with PHA and PWM were done in normal, surgically thymectomized, and sham operated rats after 7, 14, and 28 days. Each group contained six rats. No differences were found from normal in all organs.
Similar studies with PHA and PWM were also done on 27 normal rats treated with intraperitoneal hydrocortisone acetate or succinate in doses sufficient to cause thymic atrophy (Table II) . The animals were studied 2 and 4 days after the first administration of corticosteroid. No differences were noted from normal in all organs.
Similar studies with PHA and PWM were done in rats 7 and 14 days after injection of M. butyricum in saline or with mineral oil alone. No differences were noted from normal in all organs. (Greaves, Roitt, and Rose, 1968; Doenhoff, Davies, Leuchars, and Wallis, 1970) while those responding to PWM are different populations of cells, presumed at present to be a mixture of T and B cells (Stockman, Gallagher, Heim, South, and Trentin, 1971; Janossy and Greaves, 1972) . Those responding to bacterial lipopolysaccharides (LPS) are B cells (Janossy, Shohat, Greaves, and Dourmashkin, 1972) .
The PWM response in the normal rat thymus gland is quite large as compared to that of PHA, suggesting the presence of many B cells (Figs 1 and 2) . However, the reactive populations to PWM and PHA have been defined in studies of peripheral lymphoid organs which contain mainly mature lymphocytes. About 95 per cent. of the lymphoid cells in the thymus gland are immature (Cohen and Claman, 1971) and may respond differently to these mitogens or, in fact, many of the immature thymic lymphocytes may be B cell-like.
The differences in the response profiles to each of these mitogens in the present experiments with rats are probably due to the fact that each mitogen stimulates a different cell population.
Many explanations have been proposed to account for decreased PHA responses in splenic lymphocytes from adjuvant-treated animals. Rodey and Good (1969) previously noted a decrease in PHA responsiveness of mouse splenic lymphocytes after the intraperitoneal administration of Freund's adjuvant. These authors postulated that the effect might be related to adjuvant-induced thymic atrophy. A similar temporary depression of spleen cells to PHA stimulation was observed by Folch and Waksman (1972) within a few days of adult thymectomy in rats. However, in the present experiments, neither surgical ablation of the thymus nor corticosteroidinduced thymic atrophy induced any changes in PHA or PWM responses of lymphocytes derived from rat spleen, lymph nodes, blood, thymus, and bone marrow.
During the course of this work, Scott (1972a, b) reported that in mice C. parvum adjuvant caused an inhibition of PHA response in blood and splenic lymphocytes, as well as inhibition of response to PWM of splenic lymphoid cells. He demonstrated that spleen cells but not supernates from C. parvum treated mice would inhibit the PHA responses of normal splenic lymphoid cells. Furthermore, removal of the macrophages from the spleens of C. parvum treated animals would restore the PHA responses to normal. This is of interest since Gery and Waksman (1972) have found that normal mouse macrophages produce a factor which stimulates the PHA responsive T cells. Our data support the presence of some inhibitory effect of spleen cells from Freund's adjuvant-treated rats on the PHA responses ofnormal splenic lymphoid cells.
The PHA and PWM profiles show a decrease in PHA responsiveness in splenic lymphocytes and a decrease in PWM responsiveness in the blood, bone marrow, and thymic lymphocytes. There is a coincidental increase of PHA and PWM responses in lymphocytes from inguinal lymph nodes which do not drain the primary injection site of adjuvant. This suggests that Freund's adjuvant may bring about a redistribution of both T and possibly B lymphocytes with their accumulation in peripheral lymph nodes. This does not rule out the possibility that local maturation and proliferative changes may play some role.
The present experiments with Freund's adjuvant fail to show the inhibition of response of blood lymphocytes to PHA and splenic lymphocytes to PWM shown by Scott (1972a) .
The differences between these experiments and those in mice may be due to the type of adjuvant used, to its mode of administration, or to species differences. Since the rat is the only species which develops a rheumatic disease in response to Freund's adjuvant, further definition of these differences in relation to the function of adjuvants in general and of AID in particular will be required to determine whether these differences are at all related to the cause of AID, to the results of this disease, or to a combination of both.
Summary
The mitogenic responses to PHA, PWM, and bacterial LPS were studied in lymphocytes from spleen, lymph nodes, blood, thymus, and bone marrow both in normal rats and in rats with adjuvant-induced disease. The changes in PHA and PWM responses largely differed from each other in the various organs studied. There was a decreased response of adjuvanttreated spleen cells to PHA and of blood, thymus, and bone marrow to PWM. There was an increased responsiveness of lymph node cells to PHA and PWM. Responses to bacterial LPS remained essentially normal. These data differ from those in adjuvanttreated mice. Whether these differences are related to the cause of adjuvant-induced disease, to the effect of the disease, or to a combination of these factors remains to be determined. 
